Skip to Main Content

Paper Details

A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors.
Clin Cancer Res
11
2022
Author NameAffiliation
Celestia S HiganoUniversity of Washington and Fred Hutchinson Cancer Research Center
Johann S de BonoThe Institute of Cancer Research and Royal Marsden
Dana E RathkopfMemorial Sloan Kettering Cancer Center and Weill Cornell Medicine
Elisabeth I HeathKarmanos Cancer Institute, Wayne State University School of Medicine
Lillian L SiuPrincess Margaret Cancer Center, University Health Network, University of Toronto
Lillian L SiuUniversity of Toronto
  • 1 - 6

Datasets

Release 1.2